Lv11
50 积分 2023-09-12 加入
New target DDR1: A “double-edged sword” in solid tumors
6天前
已完结
Diethanolamine Boronic Esters: Development of a Simple and Standard Process for Boronic Ester Synthesis
24天前
已完结
Palbociclib Commercial Manufacturing Process Development. Part I: Control of Regioselectivity in a Grignard-Mediated SNAr Coupling
24天前
已完结
Palbociclib Commercial Manufacturing Process Development. Part II: Regioselective Heck Coupling with Polymorph Control for Processability
24天前
已完结
Development of Highly Potent and Selective Covalent FGFR4 Inhibitors Based on SNAr Electrophiles
1个月前
已完结
Structure-Guided Discovery of Aminoquinazolines as Brain-Penetrant and Selective LRRK2 Inhibitors
1个月前
已完结
Advancement of DDR1 and DDR2 Inhibitors: Therapeutic Potential of Bioactive Compounds, Designing Strategies, and Structure‐Activity Relationship (SAR)
2个月前
已完结
DDR1-targeted therapies: current limitations and future potential
2个月前
已完结
BET–HDAC Dual Inhibitors for Combinational Treatment of Breast Cancer and Concurrent Candidiasis
2个月前
已完结
In silico screening combined with bioactivity evaluation to identify AMI-1 as a novel anticancer compound by targeting AXL
2个月前
已完结
皖公网安备34019202002308
